ArticleNature medicine2021

Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial.

Benjamin C Creelan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.